(R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid, 95.0%, 100g

N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)thiomorpholine-4-carboxamide, 98%, 250mg

2-BROMO-5-FLUORO-4-NITROBENZOIC ACID, 95%, 1g

4'-Hydroxyvalerophenone>98.0%(T)(GC)25g

4-Hydroxy-2,5-dimethylfuran-3(2H)-one, 95.0%, 25g

5-(TRIFLUOROMETHYL)-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID, 95.0%, 1g

2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-8-(tert-butoxycarbonyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid, 97%, 1g

2-Amino-6-methoxybenzaldehyde, 98+%, 250mg

4,6-Dimethylpyrimidin-5-ol, 95.0%, 100mg

7-BROMO-4,5-DIHYDRO-1H-BENZO[B]AZEPIN-2(3H)-ONE, 95%, 250mg

3-CHLORO-2-FLUORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZONITRILE, 95.0%, 1g

1-methyl-N-(2-methylpropyl)piperidin-4-amine, 95.0%, 1g

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 150, 100 ml, 120 mm, 1 Piece